Compounds > 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide
Page last updated: 2024-10-23

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Pheochromocytoma, Extra-Adrenal

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies

bisindolylmaleimide II: protein kinase C inhibitor; see also bisindolylmaleimide I

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahata, M1
Mahapatra, NR1
O'Connor, DT1
Mahata, SK1

Other Studies

1 other study available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Pheochromocytoma, Extra-Adrenal

ArticleYear
Chromaffin cell catecholamine secretion: bisindolylmaleimide compounds exhibit novel and potent antagonist effects at the nicotinic cholinergic receptor in pheochromocytoma cells.
    Molecular pharmacology, 2002, Volume: 61, Issue:6

    Topics: Animals; Binding, Competitive; Catecholamines; Chromaffin Cells; Enzyme Activation; Enzyme Inhibitor

2002